|
1
|
Raposo G and Stoorvogel W: Extracellular
vesicles: Exosomes, microvesicles, and friends. J Cell Biol.
200:373–383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boysen J, Nelson M, Magzoub G, Maiti GP,
Sinha S, Goswami M, Vesely SK, Shanafelt TD, Kay NE and Ghosh AK:
Dynamics of microvesicle generation in B-cell chronic lymphocytic
leukemia: Implication in disease progression. Leukemia. 31:350–360.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu X, You Y, Li Q, Zeng C, Fu F, Guo A,
Zhang H, Zou P, Zhong Z, Wang H, et al: BCR-ABL1-positive
microvesicles transform normal hematopoietic transplants through
genomic instability: Implications for donor cell leukemia.
Leukemia. 28:1666–1675. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ntziachristos P, Abdel-Wahab O and
Aifantis I: Emerging concepts of epigenetic dysregulation in
hematological malignancies. Nat Immunol. 17:1016–1024. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang LQ and Chim CS: DNA methylation of
tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
Epigenomics. 7:461–473. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
San J, ose-Eneriz E, Agirre X,
Rodríguez-Otero P and Prosper F: Epigenetic regulation of cell
signaling pathways in acute lymphoblastic leukemia. Epigenomics.
5:525–538. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fong CY, Morison J and Dawson MA:
Epigenetics in the hematologic malignancies. Haematologica.
99:1772–1783. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou JD, Wang YX, Zhang TJ, Yang DQ, Yao
DM, Guo H, Yang L, Ma JC, Wen XM, Yang J, et al: Epigenetic
inactivation of DLX4 is associated with disease progression in
chronic myeloid leukemia. Biochem Biophys Res Commun.
463:1250–1256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esposito N, Colavita I, Quintarelli C,
Sica AR, Peluso AL, Luciano L, Picardi M, Del Vecchio L, Buonomo T,
Hughes TP, et al: SHP-1 expression accounts for resistance to
imatinib treatment in Philadelphia chromosome-positive cells
derived from patients with chronic myeloid leukemia. Blood.
118:3634–3644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Elias MH, Baba AA, Husin A, Sulong S,
Hassan R, Sim GA, Wahid SF Abdul and Ankathil R: HOXA4 gene
promoter hypermethylation as an epigenetic mechanism mediating
resistance to imatinib mesylate in chronic myeloid leukemia
patients. Biomed Res Int. 2013:1297152013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chmelarova M, Kos S, Dvorakova E, Spacek
J, Laco J, Ruszova E, Hrochova K and Palicka V: Importance of
promoter methylation of GATA4 and TP53 genes in endometrioid
carcinoma of endometrium. Clin Chem Lab Med. 52:1229–1234. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de Souza CR, Leal MF, Calcagno DQ, Sozinho
EK Costa, Borges BN, Montenegro RC, Dos Santos AK, Dos Santos SE,
Ribeiro HF, Assumpção PP, et al: MYC deregulation in gastric cancer
and its clinicopathological implications. PLoS One. 8:e644202013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang TJ, Zhou JD, Yang DQ, Wang YX, Yao
DM, Ma JC, Wen XM, Guo H, Lin J and Qian J: Hypermethylation of
DLX4 predicts poor clinical outcome in patients with
myelodysplastic syndrome. Clin Chem Lab Med. 54:865–871. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rupaimoole R, Calin GA, Lopez-Berestein G
and Sood AK: miRNA deregulation in cancer cells and the tumor
microenvironment. Cancer Discov. 6:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang YA, Lin RK, Tsai YT, Hsu HS, Yang YC,
Chen CY and Wang YC: MDM2 overexpression deregulates the
transcriptional control of RB/E2F leading to DNA methyltransferase
3A overexpression in lung cancer. Clin Cancer Res. 18:4325–4333.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Taylor DD and Gercel-Taylor C: The origin,
function, and diagnostic potential of RNA within extracellular
vesicles present in human biological fluids. Front Genet.
4:1422013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Setti M, Osti D, Richichi C, Ortensi B,
Del Bene M, Fornasari L, Beznoussenko G, Mironov A, Rappa G, Cuomo
A, et al: Extracellular vesicle-mediated transfer of CLIC1 protein
is a novel mechanism for the regulation of glioblastoma growth.
Oncotarget. 6:31413–31427. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jin Y, Zhou J, Xu F, Jin B, Cui L, Wang Y,
Du X, Li J, Li P, Ren R, et al: Targeting methyltransferase PRMT5
eliminates leukemia stem cells in chronic myelogenous leukemia. J
Clin Invest. 126:3961–3980. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lissa D and Robles AI: Methylation
analyses in liquid biopsy. Transl Lung Cancer Res. 5:492–504. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heller G, Topakian T, Altenberger C,
Cerny-Reiterer S, Herndlhofer S, Ziegler B, Datlinger P, Byrgazov
K, Bock C, Mannhalter C, et al: Next-generation sequencing
identifies major DNA methylation changes during progression of
Ph+ chronic myeloid leukemia. Leukemia. 30:1861–1868.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Amabile G, Di Ruscio A, Müller F, Welner
RS, Yang H, Ebralidze AK, Zhang H, Levantini E, Qi L, Martinelli G,
et al: Dissecting the role of aberrant DNA methylation in human
leukaemia. Nat Commun. 6:70912015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han F, Liu W, Jiang X, Shi X, Yin L, Ao L,
Cui Z, Li Y, Huang C, Cao J, et al: SOX30, a novel epigenetic
silenced tumor suppressor, promotes tumor cell apoptosis by
transcriptional activating p53 in lung cancer. Oncogene.
34:4391–4402. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kikuyama M, Takeshima H, Kinoshita T,
Okochi-Takada E, Wakabayashi M, Akashi-Tanaka S, Ogawa T, Seto Y
and Ushijima T: Development of a novel approach, the
epigenome-based outlier approach, to identify tumor-suppressor
genes silenced by aberrant DNA methylation. Cancer Lett.
322:204–212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li L, Tang J, Zhang B, Yang W, LiuGao M,
Wang R, Tan Y, Fan J, Chang Y, Fu J, et al: Epigenetic modification
of MiR-429 promotes liver tumour-initiating cell properties by
targeting Rb binding protein 4. Gut. 64:156–167. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Camussi G, Deregibus MC, Bruno S, Grange
C, Fonsato V and Tetta C: Exosome/microvesicle-mediated epigenetic
reprogramming of cells. Am J Cancer Res. 1:98–110. 2011.PubMed/NCBI
|
|
26
|
Antonyak MA and Cerione RA: Microvesicles
as mediators of intercellular communication in cancer. Methods Mol
Biol. 1165:147–173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ratajczak MZ, Ratajczak D and Pedziwiatr
D: Extracellular microvesicles (ExMVs) in cell to cell
communication: A role of telocytes. Adv Exp Med Biol. 913:41–49.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
ElSharawy A, Röder C, Becker T, Habermann
JK, Schreiber S, Rosenstiel P and Kalthoff H: Concentration of
circulating miRNA-containing particles in serum enhances miRNA
detection and reflects CRC tissue-related deregulations.
Oncotarget. 7:75353–75365. 2016.PubMed/NCBI
|
|
29
|
Espinosa-Parrilla Y, Muñoz X, Bonet C,
Garcia N, Venceslá A, Yiannakouris N, Naccarati A, Sieri S, Panico
S, Huerta JM, et al: Genetic association of gastric cancer with
miRNA clusters including the cancer-related genes MIR29, MIR25,
MIR93 and MIR106: Results from the EPIC-EURGAST study. Int J
Cancer. 135:2065–2076. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang HM, Li Q, Zhu X, Liu W, Hu H, Liu T,
Cheng F, You Y, Zhong Z, Zou P, et al: miR-146b-5p within
BCR-ABL1-positive microvesicles promotes leukemic transformation of
hematopoietic cells. Cancer Res. 76:2901–2911. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lv Z, Wei Y, Wang D, Zhang CY, Zen K and
Li L: Argonaute 2 in cell-secreted microvesicles guides the
function of secreted miRNAs in recipient cells. PLoS One.
9:e1035992014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Turchinovich A, Weiz L and Burwinkel B:
Isolation of circulating microRNA associated with RNA-binding
protein. Methods Mol Biol. 1024:97–107. 2013. View Article : Google Scholar : PubMed/NCBI
|
